Angiotensin converting enzyme inhibitors and their formulation a

Details Angiotensin converting enzyme inhibitors and their formulation a Angiotensin converting enzyme inhibitors and their formulation a

1985-11-14

1988-05-31

Bond, Robert T.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

514482, 514114, 514 86, 514 89, 514 94, 514 92, 514 95, 514 96, 514 99, 514100, 514211, 514259, 514256, 514311, 514357, 514365, 514367, 514374, 514375, 514394, 514399, 514443, 514438, 514469, 514471, 544283, 544335, 546125, 546332, 562439, 562426, 562507, 562560, 558154, 540489, 549 58, 549 76, 549 77, 548467, 548491, 548495, 548561, 548305, 548341, 548217, 548236, 548180, 548204, A61K 3155, C07D28536

Patent

active

047481609

ABSTRACT:
There are described compounds of formula I,

REFERENCES:
patent: 2514219 (1950-07-01), Shotton

Affiliated with

Also associated with

Rating

Angiotensin converting enzyme inhibitors and their formulation a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Angiotensin converting enzyme inhibitors and their formulation a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin converting enzyme inhibitors and their formulation a will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1874364